Patents Examined by Manuel Mendez
  • Patent number: 11690987
    Abstract: A device for targeted delivery of a substance to an airway may include a conduit and at least two applicators. The conduit may include a proximal end and a bifurcated distal portion having two distal ends. Each applicator may be coupled with one of the distill ends of the conduit and may be configured to direct the substance out of the applicator toward one of two sides of an airway. A method for targeted delivery of a substance to an airway may involve advancing a substance delivery device into the airway, contacting two sides of the airway with at least two applicators of the substance delivery device, such that each applicator contacts the airway near a glossopharyngeal nerve and/or a superior laryngeal nerve on each of the two sides of the airway, and delivering the substance through the applicators to contact the airway along the two sides.
    Type: Grant
    Filed: July 26, 2019
    Date of Patent: July 4, 2023
    Assignee: Awair, Inc.
    Inventors: Rush L. Bartlett, II, Ryan J. F. Van Wert, Stephen J. Ruoss, Amy E. Bartlett
  • Patent number: 11688500
    Abstract: Infusion systems, infusion devices, and related operating methods are provided. An exemplary method of operating an infusion device capable of delivering fluid to a patient involves obtaining, by a control system associated with the infusion device, user input indicating an activity by the patient, obtaining historical data for the patient corresponding to the activity, determining a probable patient response corresponding to the activity based at least in part on the historical data for the patient, determining an adjustment for delivering the fluid by the infusion device based at least in part on the probable patient response, and operating the infusion device to deliver the fluid to the patient in accordance with the adjustment.
    Type: Grant
    Filed: October 26, 2020
    Date of Patent: June 27, 2023
    Assignee: MEDTRONIC MINIMED, INC.
    Inventors: Mahta Sadeghzadeh, Benyamin Grosman, David Legray, Ulrich H. Rankers, Anirban Roy, Steven J. Vargas
  • Patent number: 11684716
    Abstract: Disclosed are techniques to establish a modified pump rate that mitigates the effects of a pump occlusion and enables a recommended dosage of insulin to be output by a pump mechanism over the course of a control cycle. In an example, the pump rate may be reduced by adding a calculated time interval between application of actuation commands to extend the amount of time over which insulin may be output by the pump mechanism.
    Type: Grant
    Filed: July 31, 2020
    Date of Patent: June 27, 2023
    Assignee: INSULET CORPORATION
    Inventors: Yibin Zheng, Joon Bok Lee, Jason O'Connor
  • Patent number: 11679201
    Abstract: A blood glucose control system can generate an indication of total carbohydrate therapy over a period during use by a subject. The system can be connected to a medicament pump configured to deliver insulin therapy, other types of medicament therapy, or a combination of medicament therapies to the subject. The system can determine an amount of a counter-regulatory agent to respond to an impending risk of hypoglycemia or an episode of hypoglycemia and determine a dose of carbohydrate therapy based at least in part on the amount of the counter-regulatory agent. The system can track determined doses of carbohydrate therapy to generate the indication of total carbohydrate therapy over the period.
    Type: Grant
    Filed: June 16, 2021
    Date of Patent: June 20, 2023
    Assignee: BETA BIONICS, INC.
    Inventors: Firas H. El-Khatib, Edward R. Damiano
  • Patent number: 11679199
    Abstract: Devices, systems, and methods are provided herein for delivering medication (e.g., insulin) via a wearable pump having a patch-style form factor for adhesion to a user's body. The reusable pump may be coupled to a disposable cap housing a microdosing system for delivering precise, repeatable doses of medication to a cannula configured to deliver medication to a target infusion area beneath the user's outer skin layer. The system further may include an applicator for inserting the cannula into the user's skin and/or applying an adhesive pad to the skin.
    Type: Grant
    Filed: November 22, 2022
    Date of Patent: June 20, 2023
    Assignee: AMF Medical SA
    Inventors: Antoine Barraud, Benjamin Pruijs, Nathanael Sigg, Christophe Satorre
  • Patent number: 11672949
    Abstract: A delivery system for an intracorporeal device includes a sheath defining one or more lumens shaped to receive a delivery catheter or shaft and a guidewire. The system may include a delivery shaft having a distal coupling feature adapted to releasably couple with a proximal coupling feature of the intracorporeal device. The delivery system may further include a hub through which the delivery shaft and guidewire are passed. The delivery shaft may be coupled to a feature, such as a knob, that enables manipulation of the delivery shaft to decouple the distal fixation feature from the proximal fixation feature of the intracorporeal device in order to deploy the intracorporeal device within a patient.
    Type: Grant
    Filed: December 14, 2020
    Date of Patent: June 13, 2023
    Assignee: Pacesetter, Inc.
    Inventors: Tracee Eidenschink, Jin Woo Park, Jason A. White
  • Patent number: 11672902
    Abstract: A method of maintaining an overall flow rate during a sequential delivery of at least two fluids to a patient's blood vessel includes delivering at least a first fluid into the patient's blood vessel at a first flow rate, delivering at least a second fluid into the patient's blood vessel at a second flow rate, and adjusting at least one of a first flow profile of the first flow rate and a second flow profile of the second flow rate to dampen a transient increase in the overall flow rate during a transition between delivering one of the first fluid and the second fluid to delivering the other of the first fluid and the second fluid.
    Type: Grant
    Filed: January 25, 2021
    Date of Patent: June 13, 2023
    Assignee: BAYER HEALTHCARE LLC
    Inventors: Michael Spohn, Ralph Schriver, Arthur Uber, III, Ronald Heller, Kevin Cowan, Barry Tucker, Edward Rhinehart, Timothy Newing
  • Patent number: 11666703
    Abstract: A biosensor includes an optical circuit that obtains a plurality of photoplethysmography (PPG) signals from light at different wavelengths that is reflected from or transmitted through tissue of a user. A processing circuit determines a measurement value for a nitric oxide (NO) level in blood flow using first and second PPG signals and determines an insulin response from caloric intake using the measurement value for the NO level in blood flow. The first PPG signal is obtained from light at a wavelength having a high absorption coefficient for NO in blood flow and the second PPG signal is obtained from light at a second wavelength having a low absorption coefficient for NO in blood flow. The processing circuit also determines one or more phases of digestion using at least one or more of the plurality of PPG signals.
    Type: Grant
    Filed: August 17, 2020
    Date of Patent: June 6, 2023
    Assignee: TRILINEAR BIOVENTURES, LLC
    Inventors: Robert Steven Newberry, Matthew Rodencal
  • Patent number: 11660393
    Abstract: An implantable emergency management drug delivery system configured to deliver a medicament to reverse the effects of a drug overdose. The implantable emergency management drug delivery system including an implantable infusion pump configured to infuse a first medicament, and an emergency handling device having at least one physiological sensor configured to monitor a condition of a patient for a possibility of an overdose from the first medicament, a communication module configured to communicate the possibility of an overdose to the implantable infusion pump, and an implantable medicament delivery mechanism configured to deliver a second medicament to reduce one or more adverse physiological effects of the first medicament.
    Type: Grant
    Filed: April 24, 2020
    Date of Patent: May 30, 2023
    Assignee: Medtronic, Inc.
    Inventor: Touby A. Drew
  • Patent number: 11648378
    Abstract: Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue. In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspensions of one or more ingredients. In embodiments of the present invention, amounts of the formulation and/or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.
    Type: Grant
    Filed: September 6, 2019
    Date of Patent: May 16, 2023
    Assignee: Neurotronic, Inc.
    Inventors: Lixiao Wang, John J. Chen, Yongxing Zhang
  • Patent number: 11648348
    Abstract: A medicament delivery device includes a generally elongated tubular housing having opposite proximal and distal parts; a needle shield sleeve slidably and coaxially arranged inside the housing with a proximal part of the sleeve protruding a distance outside the proximal part of the housing; a syringe carrier mechanism having a syringe carrier slidably and coaxially arranged within the needle shield sleeve, a syringe having a stopper, a medicament, and a needle, the syringe being coaxially arranged within the syringe carrier; and a holding member connected to the syringe carrier; a first activator member an a second activator member; a drive mechanism adapted to accumulate a drive force for moving the syringe carrier mechanism in a first step and a second step. The second activator member is arranged within an information device for producing audible, visual, and/or tactile feedback to a user about a completed injection.
    Type: Grant
    Filed: December 7, 2020
    Date of Patent: May 16, 2023
    Assignee: SHL MEDICAL AG
    Inventor: Oscar Alexandersson
  • Patent number: 11642234
    Abstract: A bariatric device and method of causing at least partial satiety in a recipient includes positioning a body in a recipient, the body having a wall defining a lumen, the wall configured to generally conform to the shape and size of the proximal cardiac portion of the stomach. Force is exerted with the wall on the proximal cardiac portion of the stomach in the absence of food thereby activating receptors located in the proximal cardiac portion of the stomach, thereby influencing a neurohormonal feedback mechanism of the recipient to cause at least partial satiety by augmenting fullness caused by food and simulating fullness in the absence of food.
    Type: Grant
    Filed: August 27, 2020
    Date of Patent: May 9, 2023
    Assignee: BFKW, LLC
    Inventors: Randal S. Baker, Paul R. Kemmeter, James A. Foote
  • Patent number: 11633300
    Abstract: A device for delivering a treatment medium to an eye includes a first body portion configured to be removably inserted and secured in an opening of the eye, and a second body portion supported by the first body portion. At least the second body portion includes a treatment medium, and a coating having an opening through which the treatment medium elutes out of the device.
    Type: Grant
    Filed: March 2, 2020
    Date of Patent: April 25, 2023
    Assignee: Mati Therapeutics Inc.
    Inventor: Eliot Lazar
  • Patent number: 11628251
    Abstract: A wearable drug delivery device, techniques, and computer-readable media that provide an application that implements a diabetes treatment plan for a user are described. The drug delivery device may include a controller operable to direct operation of the wearable drug delivery device. The controller may provide a selectable activity mode of operation for the user. Operation of the drug delivery device in the activity mode of operation may reduce a likelihood of hypoglycemia during times of increased insulin sensitivity for the user and may reduce a likelihood of hyperglycemia during times of increased insulin requirements for the user. The activity mode of operation may be manually activated by the user or may be activated automatically by the controller. The controller may automatically activate the activity mode of operation based on a detected activity level of the user and/or a detected location of the user.
    Type: Grant
    Filed: September 27, 2019
    Date of Patent: April 18, 2023
    Assignee: INSULET CORPORATION
    Inventors: Jason O'Connor, Joon Bok Lee, Trang Ly, Todd Vienneau, Yibin Zheng, Ashutosh Zade
  • Patent number: 11623044
    Abstract: Implementations illustrated herein discloses a method of controlling drug titration to a patient, the method including receiving, using a processor, a sequence of depth images, each depth image including depth information for at least a portion of the patient, determining, using the processor, a sequence of physiological signals for the patient based on the sequence of depth images, analyzing, using the processor, the sequence of physiological signals for the patient to determine a change in a condition of the patient, and generating a signal to a drug infusion pump in response to determining the change in the condition of the patient.
    Type: Grant
    Filed: February 28, 2020
    Date of Patent: April 11, 2023
    Assignee: Covidien LP
    Inventor: Paul S. Addison
  • Patent number: 11617830
    Abstract: A medical pump includes a reader configured to read drug identification information, a storage unit that stores the drug identification information read by the reader, a notification unit, and a control unit, in which when the reader reads drug identification information anew while the drug identification information is stored in the storage unit, the control unit compares the drug identification information being stored in the storage unit with the drug identification information read anew by the reader, and when the drug identification information being stored in the storage unit does not match the drug identification information read anew by the reader, the control unit causes the notification unit to notify of non-matching between drugs.
    Type: Grant
    Filed: March 6, 2020
    Date of Patent: April 4, 2023
    Assignee: TERUMO KABUSHIKI KAISHA
    Inventor: Takayuki Katsunuma
  • Patent number: 11617831
    Abstract: An intravenous delivery system may operate by gravity feed, and may have a liquid source containing a liquid, a drip unit that receives the liquid from the liquid source, and tubing that receives the liquid from the drip unit for delivery to a patient. A flow rate sensor may be used to measure a flow rate of liquid through the intravenous delivery system, and may generate a flow rate signal indicative of the flow rate. A controller may receive the signal, and may compare the flow rate with a desired flow rate. If the flow rate is more or less than the desired flow rate, the controller may transmit a control signal to a flow rate regulator. The flow rate regulator may receive the control signal and, in response, modify the flow rate to bring the flow rate closer to the desired flow rate.
    Type: Grant
    Filed: April 21, 2020
    Date of Patent: April 4, 2023
    Assignee: Becton, Dickinson and Company
    Inventors: S. Ray Isaacson, Weston F. Harding, Ralph L. Sonderegger, Austin Jason McKinnon, Milan Ivosevic
  • Patent number: 11621066
    Abstract: Infusion systems, infusion devices, and related operating methods are provided. An exemplary method of operating an infusion device capable of delivering fluid to a patient involves predicting, by a control system associated with the infusion device, a future occurrence of an event based at least in part on historical data associated with the patient, and prior to the future occurrence of the event, automatically adjusting a control parameter for operating the infusion device based at least in part on the event and automatically operating an actuation arrangement of the infusion device to deliver the fluid to the patient based at least in part on a current measurement of the physiological condition and the adjusted control parameter.
    Type: Grant
    Filed: October 26, 2020
    Date of Patent: April 4, 2023
    Assignee: MEDTRONIC MINIMED, INC.
    Inventors: Anirban Roy, Benyamin Grosman, Patrick E. Weydt, Neha J. Parikh, Louis J. Lintereur, Di Wu
  • Patent number: 11607489
    Abstract: A fluid injection system including a graphical user interface, a fluid control module operatively connected to the graphical user interface, a monitoring control module provided in at least one of the graphical user interface and the fluid control module, a fluid injector operatively connected to the graphical user interface and the fluid control module, at least one fluid path set in fluid communication with the fluid control module, and a hemodynamic monitoring system operatively connected to the fluid path set and the monitoring control module. The hemodynamic monitoring system may be configured to receive electrical signals regarding pressure waves formed in medical fluid directed through the fluid path set based on a location of the fluid path set in a patient's vasculature, to convert the electrical signals to pressure wave form information, and to send the pressure wave form information to the monitoring control module.
    Type: Grant
    Filed: May 25, 2018
    Date of Patent: March 21, 2023
    Assignee: BAYER HEALTHCARE LLC
    Inventors: Gerald Callan, Michael Spohn
  • Patent number: 11610660
    Abstract: The disclosure relates to a method which includes i) prompting input of: a creatinine clearance (CrCl) of a subject; whether the subject is being initiated or escalated on sotalol hydrochloride; an amount of an oral target dosage of sotalol hydrochloride for the subject; and optionally a projected start time for sotalol hydrochloride infusion; and ii) executing computer executable instructions to derive from a set of rules a sotalol hydrochloride dosing protocol for the subject based on the inputs. The disclosure also relates to systems and medical devices configured to perform one or more steps of the method, as well as a non-transitory computer-readable storage medium comprising computer-executable instructions or software stored thereon capable of performing one or more steps of the method.
    Type: Grant
    Filed: December 31, 2021
    Date of Patent: March 21, 2023
    Assignee: AltaThera Pharmaceuticals LLC
    Inventors: Jodi Devlin, Brandon Ira Kashfian